pharmaceuticals

Type 1 Diabetes Nanoparticle Vaccine

Type 1 Diabetes Nanoparticle Vaccine

Researchers at the University of Calgary in Canada have developed a nanoparticle vaccine for Type 1 diabetes. The vaccine, successfully tested on mice, was designed to stop the autoimmune response responsible for causing Type 1 diabetes in children without damaging ...

Read more